FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1208544001: Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4965092015 Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4965093013 Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Is a Glimepiride and rosiglitazone only product in oral dose form true Inferred relationship Some
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Glimepiride (substance) true Inferred relationship Some 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Glimepiride (substance) true Inferred relationship Some 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rosiglitazone maleate true Inferred relationship Some 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rosiglitazone (substance) true Inferred relationship Some 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Description inactivation indicator reference set

Back to Start